{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:21:48Z","timestamp":1761585708998,"version":"build-2065373602"},"posted":{"date-parts":[[2025,5,7]]},"group-title":"In Review","reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,13]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <underline>\n                    <italic>\n                      <bold>Introduction:<\/bold>\n                    <\/italic>\n                  <\/underline>\n                  <underline>\n                    <italic\/>\n                  <\/underline>\n                  <italic\/>\n                  COPD is associated with an increased AFib-related morbidity and mortality. There are several AFib risk prediction models available, but none have been validated in the COPD population.  Our study aims to (1) identify spirometric and radiographic variables that are associated with an increased risk of AFib and (2) determine if these associated variables improve the risk discrimination of established AFib risk prediction models in individuals with COPD.\n                  <underline>\n                    <italic>\n                      <bold>Methods:<\/bold>\n                    <\/italic>\n                  <\/underline>\n                  <italic\/>\n                  We evaluated 755 participants from a single center tobacco-exposed cohort at baseline, 2-, 6-, and 10-year follow up. At each study visit, the following were performed: demographic, medical history, and symptom questionnaires, PFT, and CT imaging. We performed logistic regression analysis to determine cardiopulmonary variables associated with prevalent and incident AFib. The multivariable analysis was adjusted for sex, age, number of pack years, BMI, self-reported heart failure, and anti-hypertensive medication use. Exposure variables that were statistically significant in the logistic regression analysis were added in succession to current AFib risk prediction models, CHA\n                  <sub>2<\/sub>\n                  DS\n                  <sub>2<\/sub>\n                  -VASc and CHARGE-AF, to create updated models. C-statistics were calculated for both risk scores alone as well as with each updated model.\n                  <underline>\n                    <italic>\n                      <bold>Results:<\/bold>\n                    <\/italic>\n                  <\/underline>\n                  <italic\/>\n                  DLco (OR 0.37, CI 0.16-0.83), heart volume (OR 13.12, CI 2.32-74.17), percentage of emphysema (OR 2.77, CI 1.04-7.40), and mMRC (OR 1.17, CI 1.02-1.35) were associated with prevalent AFib in the multivariable logistic regression analysis. When conducting the discrimination analysis of the AFib risk prediction scores, the addition of these cardiopulmonary variables to CHA\n                  <sub>2<\/sub>\n                  DS\n                  <sub>2<\/sub>\n                  -VASc in incident AFib was found to provide the most profound improvement, from C-statistic 0.51 to 0.70 (p&lt;0.001).\n                  <underline>\n                    <italic>\n                      <bold>Conclusions:<\/bold>\n                    <\/italic>\n                  <\/underline>\n                  <italic\/>\n                  We identified cardiopulmonary factors associated with an increased risk of AFib in a tobacco-exposed cohort. The incorporation of lung function, CT parameters, and symptom scores in validated AFib prediction models may improve AFib risk discrimination in our chronic lung disease populations.\n                  <underline>\n                    <italic>\n                      <bold>Trial Registration:<\/bold>\n                    <\/italic>\n                  <\/underline>\n                  <italic\/>\n                  This study was supported by the National Institute of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) grants 1R01HL128289 (J.B.) and P50HL084948 (F.C.S.).\n                <\/p>","DOI":"10.21203\/rs.3.rs-6439820\/v1","type":"posted-content","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:21:45Z","timestamp":1746584505000},"source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Atrial Fibrillation Risk Prediction in Tobacco-Exposed Individuals: The Role of Pulmonary Function Tests, Symptom Scores, and Imaging"],"prefix":"10.21203","author":[{"given":"Nicole","family":"Curtis","sequence":"first","affiliation":[{"name":"University of Pittsburgh School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Mehdi","family":"Nouraie","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiantao","family":"Pu","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K","family":"Leader","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank C","family":"Sciurba","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bon","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"130","key":"ref1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1183\/09059180.00008612","article-title":"Comorbidities of COPD","volume":"22","author":"Cavaill\u00e8s A","year":"2013","unstructured":"Cavaill\u00e8s A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454\u201375. 10.1183\/09059180.00008612.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/jcm13030743","article-title":"Comorbidities in COPD: Current and future treatment challenges","volume":"13","author":"Mariniello DF","year":"2024","unstructured":"Mariniello DF, D\u2019Agnano V, Cennamo D, et al. Comorbidities in COPD: Current and future treatment challenges. J Clin Med. 2024;13(3):743. 10.3390\/jcm13030743.","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijcard.2018.09.056","article-title":"Chronic obstructive pulmonary disease and the development of atrial fibrillation","volume":"276","author":"Grymonprez M","year":"2019","unstructured":"Grymonprez M, Vakaet V, Kavousi M, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2019;276:118\u201324. 10.1016\/j.ijcard.2018.09.056.","journal-title":"Int J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.hrtlng.2021.09.001","article-title":"A systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome","volume":"51","author":"Ye J","year":"2022","unstructured":"Ye J, Yao P, Shi X, Yu X. A systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome. Heart Lung. 2022;51:67\u201374. 10.1016\/j.hrtlng.2021.09.001.","journal-title":"Heart Lung"},{"issue":"5","key":"ref5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jjcc.2016.12.013","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship","volume":"69","author":"Goudis CA","year":"2017","unstructured":"Goudis CA. Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship. J Cardiol. 2017;69(5):699\u2013705. 10.1016\/j.jjcc.2016.12.013.","journal-title":"J Cardiol"},{"issue":"35","key":"ref6","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1093\/eurheartj\/ehab453","article-title":"Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: A systematic review and meta-analysis of 4,200,000 patients","volume":"42","author":"Romiti GF","year":"2021","unstructured":"Romiti GF, Corica B, Pipitone E, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: A systematic review and meta-analysis of 4,200,000 patients. Eur Heart J. 2021;42(35):3541\u201354. 10.1093\/eurheartj\/ehab453.","journal-title":"Eur Heart J"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: The CHARGE-AF consortium","volume":"2","author":"Alonso A","year":"2013","unstructured":"Alonso A, Krijthe BP, Aspelund T, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: The CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2):e000102. 10.1161\/JAHA.112.000102.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"ref8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.amjmed.2016.02.029","article-title":"Usefulness of CHADS\u2082 and CHA\u2082DS\u2082-VASc scores in the prediction of new-onset atrial fibrillation: A population-based study","volume":"129","author":"Saliba W","year":"2016","unstructured":"Saliba W, Gronich N, Barnett-Griness O, Rennert G. Usefulness of CHADS\u2082 and CHA\u2082DS\u2082-VASc scores in the prediction of new-onset atrial fibrillation: A population-based study. Am J Med. 2016;129(8):843\u20139. 10.1016\/j.amjmed.2016.02.029.","journal-title":"Am J Med"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2478\/rjim-2021-0018","article-title":"Clinical risk scores for the prediction of incident atrial fibrillation: A modernized review","volume":"59","author":"Louka AM","year":"2021","unstructured":"Louka AM, Tsagkaris C, Stoica A. Clinical risk scores for the prediction of incident atrial fibrillation: A modernized review. Rom J Intern Med. 2021;59(4):321\u20137. 10.2478\/rjim-2021-0018.","journal-title":"Rom J Intern Med"},{"issue":"3","key":"ref10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pulmoe.2021.06.001","article-title":"The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients","volume":"29","author":"Pisi R","year":"2023","unstructured":"Pisi R, Aiello M, Calzetta L, et al. The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients. Pulmonology. 2023;29(3):194\u20139. 10.1016\/j.pulmoe.2021.06.001.","journal-title":"Pulmonology"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson JL","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref12","first-page":"659","article-title":"Reference spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo RO","year":"1981","unstructured":"Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123(6):659\u201364.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395 year age range: the Global Lung Function 2012 equations","volume":"40","author":"Quanjer PH","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3\u201395 year age range: the Global Lung Function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90224-8","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston AS","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827\u201332. 10.1016\/0735-1097(90)90224-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"102367","DOI":"10.1016\/j.media.2022.102367","article-title":"Automated identification of pulmonary arteries and veins depicted in non-contrast chest CT scans","volume":"77","author":"Pu J","year":"2022","unstructured":"Pu J, Leader JK, Sechrist J, et al. Automated identification of pulmonary arteries and veins depicted in non-contrast chest CT scans. Med Image Anal. 2022;77:102367. 10.1016\/j.media.2022.102367.","journal-title":"Med Image Anal"},{"issue":"5","key":"ref16","doi-asserted-by":"publisher","first-page":"051806","DOI":"10.1117\/1.JMI.10.5.051806","article-title":"Predicting left\/right lung volumes, thoracic cavity volume, and heart volume from subject demographics to improve lung transplant","volume":"10","author":"Pu L","year":"2023","unstructured":"Pu L, Leader JK, Ali A, et al. Predicting left\/right lung volumes, thoracic cavity volume, and heart volume from subject demographics to improve lung transplant. J Med Imaging (Bellingham). 2023;10(5):051806. 10.1117\/1.JMI.10.5.051806.","journal-title":"J Med Imaging (Bellingham)"},{"key":"ref17","unstructured":"American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;81(6):e247-e350. 10.1016\/j.jacc.2022.10.017"},{"key":"ref18","volume-title":"Stata Statistical Software: Release 18. College Station","author":"StataCorp","year":"2023","unstructured":"StataCorp. Stata Statistical Software: Release 18. College Station. TX: StataCorp LLC; 2023."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ahj.2016.05.004","article-title":"A comparison of the CHARGE-AF and the CHA\u2082DS\u2082-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study","volume":"178","author":"Christophersen IE","year":"2016","unstructured":"Christophersen IE, Yin X, Larson MG, et al. A comparison of the CHARGE-AF and the CHA\u2082DS\u2082-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study. Am Heart J. 2016;178:45\u201354. 10.1016\/j.ahj.2016.05.004.","journal-title":"Am Heart J"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jacep.2019.07.016","article-title":"Development and validation of a prediction model for atrial fibrillation using electronic health records","volume":"5","author":"Hulme OL","year":"2019","unstructured":"Hulme OL, Khurshid S, Weng L-C, et al. Development and validation of a prediction model for atrial fibrillation using electronic health records. JACC Clin Electrophysiol. 2019;5(11):1331\u201341.","journal-title":"JACC Clin Electrophysiol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6439820\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6439820\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:13:31Z","timestamp":1761585211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6439820\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6439820\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12931-025-03366-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,5,7]]},"subtype":"preprint"}}